没有 BCMA?没问题:靶向 CD70 的 CAR-NK 细胞在高危骨髓瘤中展现前景
No BCMA? No Problem: A CD70-Targeting CAR-NK Cell Shows Promise in High-risk Myeloma.
79.4分
★★★★☆
站内排序·非疗效
ALL SOURCES
No BCMA? No Problem: A CD70-Targeting CAR-NK Cell Shows Promise in High-risk Myeloma.
CD70-Targeting CAR NK Cells Overcome BCMA Downregulation and Improve Survival in High-risk Multiple Myeloma Models.
State of the Art of CAR-NK Cell Therapy in Multiple Myeloma: A Comprehensive Review of Cell Sources and Target Antigens.
Recent advances in CAR T and CAR NK cell therapy for AML.
共 4 条
MEMBER ACCOUNT
登录成功会直接打开下一页。